{"id":"https://openalex.org/W4282960405","doi":"https://doi.org/10.1158/1538-7445.am2022-2812","title":"Abstract 2812: CSPG4-specific CAR.CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors","display_name":"Abstract 2812: CSPG4-specific CAR.CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282960405","doi":"https://doi.org/10.1158/1538-7445.am2022-2812"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-2812","doi":"https://doi.org/10.1158/1538-7445.am2022-2812","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-2812","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049563284","display_name":"Giulia Cattaneo","orcid":"https://orcid.org/0000-0002-7053-3238","observed_orcids":["https://orcid.org/0000-0002-7053-3238"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Cattaneo","raw_affiliation_strings":["1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051114812","display_name":"Lidia Giraudo","orcid":"https://orcid.org/0000-0002-0931-8352","observed_orcids":["https://orcid.org/0000-0002-0931-8352"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lidia Giraudo","raw_affiliation_strings":["2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072883486","display_name":"Loretta Gammaitoni","orcid":"https://orcid.org/0000-0003-2251-9578","observed_orcids":["https://orcid.org/0000-0003-2251-9578"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Loretta Gammaitoni","raw_affiliation_strings":["2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068836792","display_name":"Ilenia Iaia","orcid":"https://orcid.org/0000-0001-9698-1402","observed_orcids":["https://orcid.org/0000-0001-9698-1402"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ilenia Iaia","raw_affiliation_strings":["1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032966282","display_name":"Fabrizio Carnevale\u2010Schianca","orcid":"https://orcid.org/0000-0003-0487-1121","observed_orcids":["https://orcid.org/0000-0003-0487-1121"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabrizio Carnevale-Schianca","raw_affiliation_strings":["2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075529367","display_name":"Alberto Maria Pisacane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alberto Pisacane","raw_affiliation_strings":["2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021452701","display_name":"Enrico Berrino","orcid":"https://orcid.org/0000-0001-6728-5619","observed_orcids":["https://orcid.org/0000-0001-6728-5619"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrico Berrino","raw_affiliation_strings":["1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065261887","display_name":"Caterina Marchi\u00f2","orcid":"https://orcid.org/0000-0003-2024-6131","observed_orcids":["https://orcid.org/0000-0003-2024-6131"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Caterina Marchi\u00f2","raw_affiliation_strings":["1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044141236","display_name":"Luca Paruzzo","orcid":"https://orcid.org/0000-0002-6505-0194","observed_orcids":["https://orcid.org/0000-0002-6505-0194"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Paruzzo","raw_affiliation_strings":["1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084697072","display_name":"Andrea Michela Biolato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186903577","display_name":"University of Luxembourg","ror":"https://ror.org/036x5ad56","country_code":"LU","type":"education","lineage":["https://openalex.org/I186903577"]},{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":false,"raw_author_name":"Andrea Michela Biolato","raw_affiliation_strings":["3University of Luxembourg, Esch-sur-Alzette. Luxembourg Institute of Health, Luxembourg, Luxembourg;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of Luxembourg, Esch-sur-Alzette. Luxembourg Institute of Health, Luxembourg, Luxembourg;","institution_ids":["https://openalex.org/I186903577","https://openalex.org/I4210101141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085680955","display_name":"Chiara Donini","orcid":"https://orcid.org/0000-0003-1988-9762","observed_orcids":["https://orcid.org/0000-0003-1988-9762"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Donini","raw_affiliation_strings":["1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079227239","display_name":"Marco Basiric\u00f2","orcid":"https://orcid.org/0000-0002-3059-7501","observed_orcids":["https://orcid.org/0000-0002-3059-7501"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Basiric\u00f2","raw_affiliation_strings":["2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021996903","display_name":"Elisa Landoni","orcid":"https://orcid.org/0009-0005-8450-6256","observed_orcids":["https://orcid.org/0009-0005-8450-6256"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisa Landoni","raw_affiliation_strings":["4Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028669896","display_name":"Soldano Ferrone","orcid":"https://orcid.org/0000-0003-2900-8834","observed_orcids":["https://orcid.org/0000-0003-2900-8834"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Soldano Ferrone","raw_affiliation_strings":["5Division of Surgical Oncology, Dept. of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Division of Surgical Oncology, Dept. of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086890383","display_name":"Valeria Leuci","orcid":"https://orcid.org/0000-0003-3592-9779","observed_orcids":["https://orcid.org/0000-0003-3592-9779"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valeria Leuci","raw_affiliation_strings":["2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056702454","display_name":"Massimo Aglietta","orcid":"https://orcid.org/0000-0002-2255-7972","observed_orcids":["https://orcid.org/0000-0002-2255-7972"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimo Aglietta","raw_affiliation_strings":["1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023649972","display_name":"Gianpietro Dotti","orcid":"https://orcid.org/0000-0002-2639-8526","observed_orcids":["https://orcid.org/0000-0002-2639-8526"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gianpietro Dotti","raw_affiliation_strings":["4Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041240875","display_name":"Dario Sangiolo","orcid":"https://orcid.org/0000-0002-7163-7071","observed_orcids":["https://orcid.org/0000-0002-7163-7071"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Dario Sangiolo","raw_affiliation_strings":["1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Turin, Dept. Oncology. Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"2812","last_page":"2812"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cspg4","display_name":"CSPG4","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cytokine-induced-killer-cells","display_name":"cytokine-induced killer cells","score":0.8270000219345093},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7799999713897705},{"id":"https://openalex.org/keywords/4-1bb-costimulation","display_name":"4-1BB costimulation","score":0.7789999842643738},{"id":"https://openalex.org/keywords/nkg2d","display_name":"NKG2D","score":0.6890000104904175},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6499999761581421},{"id":"https://openalex.org/keywords/tumor-infiltrating-macrophages","display_name":"tumor-infiltrating macrophages","score":0.578000009059906},{"id":"https://openalex.org/keywords/tumor-infiltrating-neutrophils","display_name":"tumor-infiltrating neutrophils","score":0.5839999914169312},{"id":"https://openalex.org/keywords/tumor-infiltrating-dendritic-cells","display_name":"tumor-infiltrating dendritic cells","score":0.5450000166893005},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.47600001096725464},{"id":"https://openalex.org/keywords/tumor-infiltrating-b-cells","display_name":"tumor-infiltrating B cells","score":0.5680000185966492},{"id":"https://openalex.org/keywords/tumor-infiltrating-nk-cells","display_name":"tumor-infiltrating NK cells","score":0.5419999957084656},{"id":"https://openalex.org/keywords/tumor-infiltrating-treg-cells","display_name":"tumor-infiltrating Treg cells","score":0.5659999847412109},{"id":"https://openalex.org/keywords/tumor-infiltrating-myeloid-cells","display_name":"tumor-infiltrating myeloid cells","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5859194993972778},{"id":"https://openalex.org/C2778867473","wikidata":"https://www.wikidata.org/wiki/Q17544382","display_name":"NKG2D","level":4,"score":0.5820292234420776},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5205477476119995},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.49666744470596313},{"id":"https://openalex.org/C2775895372","wikidata":"https://www.wikidata.org/wiki/Q5104536","display_name":"Chondroitin sulfate proteoglycan","level":4,"score":0.4750621020793915},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.45949676632881165},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.4474041759967804},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41360944509506226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4095403850078583},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3179232180118561},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.30424976348876953},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3001028299331665},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2698785066604614},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14588597416877747},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1281965970993042},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.11815926432609558},{"id":"https://openalex.org/C2779335624","wikidata":"https://www.wikidata.org/wiki/Q407976","display_name":"Proteoglycan","level":3,"score":0.07032284140586853},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-2812","doi":"https://doi.org/10.1158/1538-7445.am2022-2812","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-2812","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7217790375","https://openalex.org/W4388908224","https://openalex.org/W4402827995","https://openalex.org/W4410803099","https://openalex.org/W2887623613","https://openalex.org/W2026104900","https://openalex.org/W4384931429","https://openalex.org/W3083451414","https://openalex.org/W2078538189","https://openalex.org/W1496451688"],"abstract_inverted_index":{"Abstract":[0],"Purpose":[1],"of":[2,11,53,99,142,182,188,234,317,335,360,368,474],"this":[3],"study":[4],"is":[5,68],"to":[6,22,42,253,326,355,402,464],"explore":[7],"the":[8,50,186,273,318,333,347,361,366,400,407,475],"preclinical":[9],"efficacy":[10],"Chondroitin":[12],"Sulfate":[13],"Proteoglycan":[14],"4":[15,177],"(CSPG4)-specific":[16],"CAR-engineered":[17],"Cytokine-Induced":[18],"Killer":[19],"lymphocytes":[20,80],"(CIK)":[21],"eradicate":[23],"melanoma":[24,58,123,178,391,411,469],"cells":[25,132,167],"with":[26,82,103,111,154,163,204,216,250,272,289,375,419],"defective":[27,378],"HLA":[28,466],"class":[29,467],"I":[30],"(HLA-I).":[31],"The":[32,140],"latter":[33],"abnormality":[34],"plays":[35],"a":[36,104,107,155,217,235,314,384],"major":[37],"role":[38],"in":[39,63,147,150,169,212,240,263,395,410],"clinical":[40,404],"resistance":[41],"Checkpoint":[43],"Inhibitors":[44],"(CI).":[45],"CSPG4":[46,138,143,242,256,283,311,369],"was":[47,117,145,184,243,285,330],"selected":[48],"as":[49,89,135,324],"target":[51],"because":[52,233],"its":[54,60],"high":[55],"expression":[56,116,181],"on":[57,70,122,346],"and":[59,149,194,269,338,392],"restricted":[61],"distribution":[62],"normal":[64],"tissues.":[65],"Our":[66,397],"approach":[67],"based":[69],"CAR.CIK":[71,93,144,165,172,257,284,312,370,461],"redirected":[72],"against":[73,371,390],"CSPG4.":[74],"CIK,":[75],"ex":[76,189],"vivo":[77,190],"expanded":[78],"T-NK":[79],"endowed":[81],"intrinsic":[83],"HLA-independent":[84],"antitumor":[85],"activity,":[86],"were":[87,94,160,173,202,210],"used":[88],"effectors.":[90],"Experimental":[91],"procedure.":[92],"generated":[95,175],"by":[96,119,128,246,282,332],"retroviral":[97],"transduction":[98],"patient":[100],"derived":[101,127],"PBMC":[102],"vector":[105],"encoding":[106],"2nd":[108],"generation":[109],"CSPG4-CAR":[110,183],"4-1BB":[112],"co-stimulation.":[113],"Surface":[114],"HLA-I":[115,208,232,254,275,379],"evaluated":[118],"flow":[120],"cytometry":[121],"cell":[124,222],"lines":[125],"(Mel),":[126],"surgical":[129],"biopsies.":[130],"These":[131],"also":[133],"served":[134],"targets":[136],"for":[137,387,478],"CAR.CIK.":[139],"activity":[141,329,340,367],"analyzed":[146],"vitro":[148],"immunodeficient":[151],"mice":[152],"grafted":[153],"patient-derived":[156],"HLA-defective":[157],"melanoma.":[158],"Mice":[159],"treated":[161],"intravenously":[162],"3x106":[164],"(5":[166],"infusions":[168],"total).":[170],"Results.":[171],"efficiently":[174,258],"from":[176],"patients.":[179],"Mean":[180,279],"48\u00b18%,":[185],"rate":[187],"expansion":[191],"(84":[192],"fold)":[193],"phenotypic":[195],"characteristics":[196],"(CD3+CD8+=71\u00b113%,":[197],"CD3+":[198],"CD56+=22.5\u00b113%,":[199],"NKG2D+=":[200],"68\u00b132.3%)":[201],"comparable":[203],"unmodified":[205,290],"controls.":[206,327],"Membrane":[207],"molecules":[209],"detected":[211],"23/24":[213],"Mel":[214,248,261,271],"samples,":[215],"variable":[218],"membrane":[219],"density":[220,276],"per":[221],"(median":[223],"21232,":[224],"range":[225],"787-49871).":[226],"Sample":[227],"Mel17":[228,266,320],"did":[229],"not":[230,413],"express":[231],"start":[236],"lost":[237],"mutation":[238],"(p.Met1Ile)":[239],"\u03b22microglobulin.":[241],"intensely":[244],"expressed":[245],"all":[247],"(78\u00b15%),":[249],"no":[251],"correlation":[252],"levels.":[255],"killed":[259],"10":[260],"samples":[262],"vitro,":[264],"including":[265,373],"(HLA-I":[267],"negative)":[268],"2":[270,356],"lowest":[274],"(Mel71,":[277],"Mel72).":[278],"Mel-specific":[280],"killing":[281],"significantly":[286],"higher":[287],"compared":[288,325],"CIK":[291,381],"especially":[292],"at":[293,301,306],"low":[294,376],"effector/target":[295],"(E/T)":[296],"ratios":[297],"(85%":[298],"vs":[299,304],"40%":[300],"E/T=1:1;":[302],"46%":[303],"9%":[305],"E/T=1:8,":[307],"p<0.0001).":[308],"In":[309],"vivo,":[310],"caused":[313],"significant":[315],"inhibition":[316],"HLA-negative":[319],"tumor":[321,336],"growth":[322],"(p<0.0001)":[323],"Antitumor":[328,351],"confirmed":[331],"reduction":[334],"weight":[337],"metabolic":[339],"(by":[341],"fluorescent":[342],"glucose":[343],"uptake)":[344],"measured":[345],"residual":[348],"explanted":[349],"tumors.":[350],"response":[352],"persisted":[353],"up":[354],"weeks":[357],"after":[358,417],"end":[359],"treatment.":[362],"Conclusions.":[363],"We":[364],"reported":[365],"melanoma,":[372],"those":[374],"or":[377,415],"expression.":[380],"may":[382],"provide":[383,399],"valid":[385],"platform":[386],"CAR-based":[388],"strategies":[389],"solid":[393],"tumors":[394,470],"general.":[396],"data":[398],"rationale":[401],"implement":[403],"studies":[405],"exploring":[406],"proposed":[408],"strategy":[409],"patients":[412],"responding":[414],"relapsing":[416],"immunotherapy":[418,463],"CI.":[420],"Citation":[421],"Format:":[422],"Giulia":[423],"Cattaneo,":[424],"Lidia":[425],"Giraudo,":[426],"Loretta":[427],"Gammaitoni,":[428],"Ilenia":[429],"Iaia,":[430],"Fabrizio":[431],"Carnevale-Schianca,":[432],"Alberto":[433],"Pisacane,":[434],"Enrico":[435],"Berrino,":[436],"Caterina":[437],"Marchi\u00f2,":[438],"Luca":[439],"Paruzzo,":[440],"Andrea":[441],"Michela":[442],"Biolato,":[443],"Chiara":[444],"Donini,":[445],"Marco":[446],"Basiric\u00f2,":[447],"Elisa":[448],"Landoni,":[449],"Soldano":[450],"Ferrone,":[451],"Valeria":[452],"Leuci,":[453],"Massimo":[454],"Aglietta,":[455],"Gianpietro":[456],"Dotti,":[457],"Dario":[458],"Sangiolo.":[459],"CSPG4-specific":[460],"lymphocyte-based":[462],"eliminate":[465],"I-defective":[468],"[abstract].":[471],"In:":[472],"Proceedings":[473],"American":[476],"Association":[477],"Cancer":[479,490],"Research":[480],"Annual":[481],"Meeting":[482],"2022;":[483],"2022":[484],"Apr":[485],"8-13.":[486],"Philadelphia":[487],"(PA):":[488],"AACR;":[489],"Res":[491],"2022;82(12_Suppl):Abstract":[492],"nr":[493],"2812.":[494]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2022-06-17T00:00:00"}